Table 4.
Sample size |
Median predictora |
Neural networka |
Neural networka,b |
Neural networka,b,c |
Neural networka,b,d |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Training | Test | Training | Test | Training | Test | Training | Test | Training | Test | Training | Test | |
PS-COOH | 88 001 | 86 429 | 0.083 | 0.075 | 0.773 | 0.593 | 0.807 | 0.473 | 0.886 | 0.536 | — | — |
PS-COOH in serum | 138 913 | 142 066 | 0.176 | 0.172 | 0.842 | 0.687 | 0.878 | 0.548 | 0.936 | 0.640 | — | — |
PS-PEG | 35 969 | 36 864 | 0.142 | 0.171 | 0.438 | 0.283 | 0.517 | 0.065 | — | — | 0.658 | 0.258 |
PS-PEG in serum | 95 111 | 93 907 | 0.029 | 0.023 | 0.879 | 0.800 | 0.878 | 0.641 | — | — | 0.967 | 0.908 |
Avg/tot | 357 994 | 359 266 | 0.107 | 0.110 | 0.838 | 0.591 | 0.770 | 0.432 | 0.911 | 0.588 | 0.812 | 0.583 |
Predictions performed using locally averaged features.
Reported recall values are averaged from 4 separate 3–1 train-test split predictors.
Predictor limited to PS-COOH nanoparticles to predict serum status.
Predictor limited to PS-PEG nanoparticles to predict serum status.